title: Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options.
authors.affiliation: Department of Urology, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California 90095, USA.
authors.forename: John S
authors.initials: JS
authors.lastname: Lam
authors.forename: John T
authors.initials: JT
authors.lastname: Leppert
authors.forename: Arie S
authors.initials: AS
authors.lastname: Belldegrun
authors.forename: Robert A
authors.initials: RA
authors.lastname: Figlin
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000601:surgery / Q000628:therapy*; D006360:Heat-Shock Proteins / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery / Q000628:therapy*; D008207:Lymphatic Metastasis / Q000517:prevention & control; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009392:Nephrectomy; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic
chemical_list: D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; C106533:G250 monoclonal antibody; D006360:Heat-Shock Proteins